Literature DB >> 22049975

Interdisciplinary approach towards female patients with Fabry disease.

Frank Weidemann1, Markus Niemann, Claudia Sommer, Meinrad Beer, Frank Breunig, Christoph Wanner.   

Abstract

BACKGROUND: Fabry disease (FD) is a rare X-linked lysosomal storage disorder leading to an accumulation of globotriaosylceramides in the lysosomes of various organs.
DESIGN: Being X-chromosomal-linked, most studies in the past have focused on involvement in male patients. However, it has been elucidated recently that female patients can present typical organ involvement and thus need to be treated, respectively.
CONCLUSIONS: This review wants to give a systematical overview of the typical organ involvement in female patients with FD. Moreover, therapy recommendations especially for female patients are discussed.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049975     DOI: 10.1111/j.1365-2362.2011.02614.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  5 in total

1.  Clinically relevant functional annotation of genotype.

Authors:  Calum A MacRae; Ramachandran S Vasan
Journal:  Circ Cardiovasc Genet       Date:  2014-02

2.  Fabry disease: the many faces of a single disorder.

Authors:  Roser Torra; Alberto Ortíz
Journal:  Clin Kidney J       Date:  2012-10

3.  Major Organic Involvement in Women with Fabry Disease in Argentina.

Authors:  Fernando Perretta; Norberto Antongiovanni; Sebastián Jaurretche
Journal:  ScientificWorldJournal       Date:  2018-05-21

4.  Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.

Authors:  Derralynn A Hughes; Patricio Aguiar; Patrick B Deegan; Fatih Ezgu; Andrea Frustaci; Olivier Lidove; Aleš Linhart; Jean-Claude Lubanda; James C Moon; Kathleen Nicholls; Dau-Ming Niu; Albina Nowak; Uma Ramaswami; Ricardo Reisin; Paula Rozenfeld; Raphael Schiffmann; Einar Svarstad; Mark Thomas; Roser Torra; Bojan Vujkovac; David G Warnock; Michael L West; Jack Johnson; Mark J Rolfe; Sandro Feriozzi
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

Review 5.  Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?

Authors:  Stephen Waldek; Sandro Feriozzi
Journal:  BMC Nephrol       Date:  2014-05-06       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.